Tiblio
Sign Up

TLPH

Talphera Inc.
NASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Key Statistics

Market Cap
$67.47M
P/E Ratio
—
EPS
$-0.29
Beta
0.70
52W High
$1.57
52W Low
$0.39
50-Day MA
$1.04
200-Day MA
$1.02
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.02
PEG Ratio
—

About Talphera Inc.

Talphera Inc. is a pioneering biotechnology company dedicated to advancing peptide-based therapies for rare diseases and significant unmet medical needs. Its promising pipeline, especially in developing innovative cancer treatments, highlights the firm's potential for substantial growth within the biopharmaceutical industry. Committed to rigorous research and focused on delivering transformative health solutions, Talphera represents a compelling investment opportunity for institutional investors seeking to capitalize on the dynamic biotech landscape.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)1,000
Gross Profit (TTM)-726,000
EBITDA$-15.16M
Operating Margin-1451600.00%
Return on Equity-118.40%
Return on Assets-40.20%
Revenue/Share (TTM)$0.00
Book Value$0.34
Price-to-Book3.54
Price-to-Sales (TTM)67469.54
EV/Revenue44285.56
EV/EBITDA0.11
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$51.90M
Float$26.98M
% Insiders21.41%
% Institutions34.76%

Historical Volatility

HV 10-Day
65.41%
HV 20-Day
72.65%
HV 30-Day
79.17%
HV 60-Day
68.60%
HV Rank
53.2%

Volatility is currently contracting

Analyst Ratings

Consensus ($3.17 target)
1
Strong Buy
1
Buy

Latest News

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

NEPHRO CRRT clinical study expected to be completed this year Cash and investments of $21.1 million at March 31, 2026 Conference call and webcast to be held on Wednesday, May 13, 2026 at 4:30 pm ET SAN MATEO, Calif., May 13, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced first quarter 2026 financial results and provided a corporate update.

PRNewsWire5/13/2026Neutral
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026

SAN MATEO, Calif., May 7, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will release first quarter 2026 financial results after market close on Wednesday, May 13, 2026, then host a live webcast and conference call at 4:30 p.m.

PRNewsWire5/7/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on TLPH and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

LLYEli Lilly and CompanyJNJJohnson & JohnsonABBVAbbVie IncUNHUnitedHealth Group IncorporatedMRKMerck & Company IncNVSNovartis AG ADRAZNAstraZeneca PLCNVONovo Nordisk A/STMOThermo Fisher Scientific IncAMGNAmgen IncABTAbbott LaboratoriesGILDGilead Sciences Inc
View all HEALTHCARE stocks →
Data last updated: 7/29/2026